🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "focused action to tackle cost of living pressures" in the upcoming financial statement.

During an interview with media outlets, she emphasized that reducing price rises is a shared duty of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven developed nations this calendar year and the following year.

Potential Utility Cost Interventions

It is understood the government could intervene to lower utility costs, for example by cutting the current 5% level of value-added tax charged on energy supplies.

A further option is to cut some of the policy costs currently included in household expenses.

Budgetary Constraints and Expert Expectations

The government will receive the next assessment from the independent fiscal watchdog, the OBR, on Monday, which will show how much space there is for such measures.

The consensus from the majority of economists is that the Chancellor will have to announce higher taxes or expenditure reductions in order to adhere to her declared debt limits.

Earlier on the same day, analysis showed there was a £22bn gap for the chancellor to fill, which is at the lower end of expectations.

"It is a collective responsibility between the central bank and the government to bear down further on some of the causes of inflation," the Chancellor stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Pledges and International Concerns

While a great deal of the attention has been on expected tax rises, the chancellor said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to raise rates on income tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with increasing international and commercial concerns for the fiscal revenue measures, probably to be focused on those "most able to pay."

International Economic Disputes

Addressing worries about the UK's trade ties with the Asian nation she said: "The UK's national security always take priority."

Last week's declaration by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are essential for high-technology production led American leader the US President to threaten an additional 100% tariff on imports from China, raising the possibility of an full-scale commercial conflict between the two economic giants.

The American finance chief called the Chinese action "commercial pressure" and "a global supply chain power grab."

Asked about accepting the American proposal to participate in its conflict with China, Reeves said she was "extremely troubled" by Chinese actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the global economy and creates additional challenges."

"It is my opinion there are fields where we must confront Chinese policies, but there are also significant prospects to trade with Chinese markets, including banking sector and other areas of the economy. We've got to achieve that equilibrium right."

The Treasury chief also stated she was cooperating with G7 counterparts "regarding our own critical minerals strategy, so that we are more independent."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the NHS pays for medicines could rise as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the world's largest drug companies have said lately that they are either delaying or canceling operations in the UK, with some attributing the modest returns they are getting.

Last month, the Science Minister said the price the NHS pays for drugs would must rise to stop companies and drug research funding departing from the UK.

Reeves informed the BBC: "We have seen due to the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other European countries."

"The objective is to ensure that patients receiving care from the NHS are can receive the top essential medicines in the world. And so we are examining all of that, and... looking to secure additional funding into Britain."